Cargando…
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
The Chimera antigen receptor (CAR)-T cell therapy has gained great success in the clinic. However, there are still major challenges for its wider applications in a variety of cancer types including lack of effectiveness due to the highly complex tumor microenvironment, and the forbiddingly high cost...
Autores principales: | Zhang, Li, Tian, Lin, Dai, Xiaoyang, Yu, Hua, Wang, Jiajia, Lei, Anhua, Zhu, Mengmeng, Xu, Jianpo, Zhao, Wei, Zhu, Yuqing, Sun, Zhen, Zhang, Hao, Hu, Yongxian, Wang, Yanlin, Xu, Yuming, Church, George M., Huang, He, Weng, Qinjie, Zhang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656711/ https://www.ncbi.nlm.nih.gov/pubmed/33176869 http://dx.doi.org/10.1186/s13045-020-00983-2 |
Ejemplares similares
-
Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors
por: Wang, Xudong, et al.
Publicado: (2023) -
Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies
por: Su, Siyu, et al.
Publicado: (2022) -
Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021) -
Regeneration of T cells from human-induced pluripotent stem cells for CAR-T cell medicated immunotherapy
por: Chen, Yanyan, et al.
Publicado: (2023) -
CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
por: Liu, Maoxuan, et al.
Publicado: (2022)